NO20043007L - Farmasoytisk suspensjon for oral administrering - Google Patents

Farmasoytisk suspensjon for oral administrering

Info

Publication number
NO20043007L
NO20043007L NO20043007A NO20043007A NO20043007L NO 20043007 L NO20043007 L NO 20043007L NO 20043007 A NO20043007 A NO 20043007A NO 20043007 A NO20043007 A NO 20043007A NO 20043007 L NO20043007 L NO 20043007L
Authority
NO
Norway
Prior art keywords
oral administration
pharmaceutical suspension
pharmaceutical
suspension
oral
Prior art date
Application number
NO20043007A
Other languages
English (en)
Inventor
Guang Wei Lu
Po-Chang Chiang
Original Assignee
Pharmacia Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Corp filed Critical Pharmacia Corp
Publication of NO20043007L publication Critical patent/NO20043007L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20043007A 2001-12-20 2004-07-15 Farmasoytisk suspensjon for oral administrering NO20043007L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US34259901P 2001-12-20 2001-12-20
PCT/US2002/039186 WO2003053403A2 (en) 2001-12-20 2002-12-09 Pharmaceutical suspension for oral administration

Publications (1)

Publication Number Publication Date
NO20043007L true NO20043007L (no) 2004-07-15

Family

ID=23342498

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20043007A NO20043007L (no) 2001-12-20 2004-07-15 Farmasoytisk suspensjon for oral administrering

Country Status (16)

Country Link
US (1) US20030157172A1 (no)
EP (1) EP1455752A2 (no)
JP (1) JP2005516943A (no)
KR (1) KR20040073493A (no)
CN (1) CN1620282A (no)
AU (1) AU2002364146A1 (no)
BR (1) BR0215261A (no)
CA (1) CA2470912A1 (no)
CO (1) CO5590886A2 (no)
IL (1) IL162510A0 (no)
MX (1) MXPA04006165A (no)
NO (1) NO20043007L (no)
PL (1) PL371133A1 (no)
RU (1) RU2004118493A (no)
WO (1) WO2003053403A2 (no)
ZA (1) ZA200404788B (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9101540B2 (en) * 2002-04-12 2015-08-11 Alkermes Pharma Ireland Limited Nanoparticulate megestrol formulations
SI2018153T1 (sl) * 2006-04-26 2012-08-31 Rosemont Pharmaceuticals Ltd Tekoči oralni sestavki
CN101610754A (zh) 2007-02-16 2009-12-23 Aska制药株式会社 含有微粒油性混悬液的药物组合物
WO2009133431A1 (en) * 2008-04-30 2009-11-05 Wockhardt Research Centre Oral liquid compositions of rhein or diacerein
WO2011107855A2 (en) 2010-03-04 2011-09-09 Torrent Pharmaceuticals Limited Sustained release oral liquid suspension dosage form
JP2018516279A (ja) * 2015-05-29 2018-06-21 コーダドース・インコーポレーテッド 経口投与用のセレコキシブの液状配合物
ITUB20155193A1 (it) * 2015-11-03 2017-05-03 Italfarmaco Spa Sospensioni orali di Givinostat fisicamente e chimicamente stabili
KR200486813Y1 (ko) 2018-02-22 2018-08-02 ㈜제이아이테크 핸드 파레트 트럭
KR102145022B1 (ko) * 2018-08-14 2020-08-14 동아제약 주식회사 이부프로펜의 현탁액 조성물 및 투여 제형

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2904469A (en) * 1957-07-29 1959-09-15 Johnson & Johnson Stabilized aqueous suspension of salicylamide
US3041239A (en) * 1959-05-28 1962-06-26 Johnson & Johnson Stable aqueous salicylamide composition and method of preparing same
US3326755A (en) * 1965-06-15 1967-06-20 Warner Lambert Pharmaceutical Alginate containing antacid compositions
IT1209276B (it) * 1980-11-05 1989-07-16 Magis Farmaceutici Composizione farmaceutica per la somministrazione orale del metilestere dell'acido 13a-etil-2,3,5,6,12,13,13a,13b-ottaidro-12-idrossi1h-indolo-[3,2,1-de] pirido [3,2,1-ij] [1,5] naftiridina -12-carbossilico
DK130287D0 (da) * 1987-03-13 1987-03-13 Benzon As Alfred Oralt praeparat
US5552160A (en) * 1991-01-25 1996-09-03 Nanosystems L.L.C. Surface modified NSAID nanoparticles
US5976570A (en) * 1993-12-21 1999-11-02 Applied Analytical Industries, Inc. Method for preparing low dose pharmaceutical products
US5455049A (en) * 1995-01-04 1995-10-03 Ascent Pharmaceuticals, Inc. Terfenadine oral powder
US5591456A (en) * 1995-02-10 1997-01-07 Nanosystems L.L.C. Milled naproxen with hydroxypropyl cellulose as a dispersion stabilizer
US5718919A (en) * 1995-02-24 1998-02-17 Nanosystems L.L.C. Nanoparticles containing the R(-)enantiomer of ibuprofen
CA2227314A1 (en) * 1997-01-24 1998-07-24 Hoechst Aktiengesellschaft Preparation of concealed taste preparations of antibacterially active quinolone derivatives
US6664287B2 (en) * 2000-03-15 2003-12-16 Bethesda Pharmaceuticals, Inc. Antioxidants

Also Published As

Publication number Publication date
WO2003053403A2 (en) 2003-07-03
CN1620282A (zh) 2005-05-25
JP2005516943A (ja) 2005-06-09
EP1455752A2 (en) 2004-09-15
RU2004118493A (ru) 2005-03-27
CO5590886A2 (es) 2005-12-30
MXPA04006165A (es) 2004-11-01
KR20040073493A (ko) 2004-08-19
PL371133A1 (en) 2005-06-13
BR0215261A (pt) 2004-12-07
AU2002364146A1 (en) 2003-07-09
ZA200404788B (en) 2005-09-01
US20030157172A1 (en) 2003-08-21
CA2470912A1 (en) 2003-07-03
IL162510A0 (en) 2005-11-20
WO2003053403A3 (en) 2004-02-26

Similar Documents

Publication Publication Date Title
EE200300523A (et) Aripiprasooli ravimlahus peroraalseks manustamiseks
NO20033556L (no) Farmasöytiske formuleringer
EE200300416A (et) Ravimvorm
NO20033384D0 (no) Farmasöytisk formulering
PT1501534E (pt) Formulacoes farmaceuticas
NO20033815D0 (no) Farmasöytiske salter
FI20011478A0 (fi) Farmaseuttinen koostumus
IS2580B (is) Platínuafleiða lyfjasamsetningar
DK1414409T3 (da) Stabiliseret oral suspensionsformulering
NO20035627D0 (no) Farmasöytisk formulering
NO20035315D0 (no) Farmasöytiske kombinasjoner
NO20014738D0 (no) Tolperisonholdig farmasöytisk preparat for oral administrering
FI20022128A0 (fi) Farmaseuttinen koostumus
NO20034556L (no) Imidazotriazinon-holdige sammensetninger for nasal administrering
DE60217390D1 (de) Bicalutamid enthaltende pharmazeutische zusammensetzung
NO20043007L (no) Farmasoytisk suspensjon for oral administrering
AU2002346457A8 (en) Pharmaceutical formulations comprising indolinone derivatives
ITMI20011240A0 (it) Farmaci per le vasculopatie
ITMI20011744A0 (it) Farmaci per le vasculopatie
DE10291905D2 (de) Pharmazeutische Zusammensetzung
FR2791888B1 (fr) Suspension pharmaceutique buvable
FI20012242A0 (fi) Uudet farmaseuttiset yhdisteet
DE10107261B4 (de) Pharmazeutische Zusammensetzung
NO20041236L (no) Farmasoytisk formulering
SE0103116D0 (sv) Pharmaceutical combination

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application